Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

Another preventive measure is monoclonal antibodies — artificially created proteins that can be given to infants to assist ...

The WA Department of Health has sent an urgent reminder to medical staff to make sure they’re giving patients the right RSV ...

The sound of rain may feel romantic to some, but for parents? It’s a seasonal alarm bell. Not just puddles and power cuts, an annual wave of infections that hit kids the hardest.

The recommendation for Enflonsia is indicated for respiratory syncytial virus prevention in infants under eight months of age, expanding protection options ahead of the 2025–2026 season.

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

In recent weeks, Health and Human Services Secretary Robert F. Kennedy Jr. has begun to dismantle decades of vaccine safety ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...